DIACOMIT®(stiripentol) is an effective, FDA-approved antiseizure medication developed specifically for seizures associated with Dravet syndrome in patients 6 months and older, weighing 15 lb or more and taking clobazam. There are no clinical data to support the use of DIACOMIT as a monotherapy in Dravet syndrome.1